about
Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization.A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity.Promoter DNA methylation of farnesoid X receptor and pregnane X receptor modulates the intrahepatic cholestasis of pregnancy phenotype.Association between diencephalic thyroliberin and arterial blood pressure in agouti-yellow and ob/ob mice may be mediated by leptin.Insulin resistance and epigenetic regulation: insights from human studies and prospects for future research.Seroprevalence of St. Louis encephalitis virus and West Nile virus (Flavivirus, Flaviviridae) in horses, Uruguay.Serotonin and serotonin transporter gene variant in rotating shift workers.Fatal human case of Western equine encephalitis, Uruguay.Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease.Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor γ coactivator 1α promoter.Gene-gene interaction between serotonin transporter (SLC6A4) and CLOCK modulates the risk of metabolic syndrome in rotating shiftworkers.The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy.The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease.Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease.Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension.Comparison of the effects of 3,5,3'-triiodothyroacetic Acid and triiodothyronine on goiter prevention and involution and on hepatic and skeletal parameters in rats.Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model.Mitochondrial DNA copy number is modulated by genetic variation in the signal transducer and activator of transcription 3 (STAT3).Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model.Study of genetic variation in the STAT3 on obesity and insulin resistance in male adults.Contribution of the functional 5-HTTLPR variant of the SLC6A4 gene to obesity risk in male adults.SiRNA-mediated silencing of the diencephalic thyrotropin-releasing hormone precursor gene decreases the arterial blood pressure in the obese agouti mice.Odor perception between heterosexual partners: its association with depression, anxiety, and genetic variation in odorant receptor OR7D4.Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat.Maternal high-fat intake during pregnancy programs metabolic-syndrome-related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPARGC1A.Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation.A diagnostic model to differentiate simple steatosis from nonalcoholic steatohepatitis based on the likelihood ratio form of Bayes theorem.Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severityCyclooxygenase inhibition Up-regulates liver carnitine palmitoyltransferase 1A expression and improves fatty liverIncreased levels of resistin in rotating shift workers: A potential mediator of cardiovascular risk associated with circadian misalignmentThe impact of maternal high-fat feeding on liver and abdominal fat accumulation in adult offspring under a long-term high-fat dietCirculating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver diseaseGenetic Variation in the FAAH Gene and Metabolic Syndrome–related PhenotypesGenetic variants of Clock transcription factor are associated with individual susceptibility to obesityShould Nonalcoholic Fatty Liver Disease Be Included in the Definition of Metabolic Syndrome? A Cross-Sectional Comparison With Adult Treatment Panel III Criteria in Nonobese Nondiabetic Subjects: Response to Musso et alAssociation of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancySystematic review and meta-analysis on the relationship between prenatal stress and metabolic syndrome intermediate phenotypes
P50
Q35010425-4588DCE0-88E8-48B5-A752-0A8475DB0059Q37337449-4B326C64-6E88-46FD-84B7-892C380A7864Q37539016-2EB1B9B0-5603-45A3-9E34-6A424C2DDA67Q38298141-5C5BAC1B-4FEC-4A9C-A71F-B08BFD36789DQ38472623-9D0F70E6-868A-4C68-9D0F-C9978E13C51AQ41871543-729450AC-4DAA-4285-BEB0-6E4B365DA9B9Q42370308-3B81C4EB-67BF-4412-B125-146F91F3E17AQ42553627-79546E79-48E7-4740-B828-464B67D062C8Q42732480-5E078970-86E2-4CED-9BF6-CD41332E99C3Q42870876-E8E4338E-383B-48E2-9A35-80B4392F59EAQ42961005-1D4A8A9A-4063-4272-8B5D-E1C26436905BQ43230788-0ED314CA-5F74-40E3-AAB7-AD218ECDB51EQ43235201-A5881980-A02A-4B52-9A33-CC0B7999EEFBQ43761846-39B972E0-1891-489A-9B3A-B2F1C65E45A5Q43804806-8C86BD71-55BA-4126-90D8-867E924054BDQ44905326-CB629478-BC32-4EC7-AE8A-72BC0F8CF2F9Q45014583-E3CF17EE-08F9-4E51-94CE-904D69031043Q45026894-32330E93-4A20-4CAA-8560-C8E04027F265Q46115586-3A0B973F-586D-464D-B941-3872F2640469Q46615575-2686194D-99A1-4C7C-B6B4-BDCF7EA326B8Q46779229-64CD1CCF-190A-46EF-8F0C-44A5CE0D9AF2Q48176371-9FA3764C-9CED-4599-95F0-5549E99419F0Q48959224-2F319157-21BD-423C-A7D2-154F8E264FDDQ50701186-3F37BC3E-362C-4ACA-8909-F5965D077EF1Q51334855-52CEDA50-69AC-4A1F-AD63-2FBB9E1E809BQ51477953-CD9E8BF6-DFEB-48B4-8329-ED95041194ADQ51860456-BC18D4D4-EF6B-4159-8BE4-BB51044BC8F5Q60938634-83D1B9A4-33DB-486F-B07A-8B5F41BA49EFQ60938739-DA140B0E-6AA6-49A0-89DD-1651DA5B12F2Q60938771-18C867EA-C212-4C36-BD34-560D3D76B359Q60938783-933801DD-B8B7-4CAC-B9C4-E9A4335FA687Q60938790-E9D2CFC2-3A00-474B-ADE9-B93CFCC4664AQ60938810-143EE285-AD66-4B75-962A-B25B7EF4326BQ60938833-B2A9B895-1D41-4C80-80DB-F5CA7C225BC8Q60938841-CFBD230D-5BF5-4E46-A30B-0DE5ECA26102Q60938853-41107568-D47E-46AD-A17C-C8C0580BF684Q92092965-8EDD4FB5-9933-43AB-A5F5-C181051364CA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adriana L Burgueño
@ast
Adriana L Burgueño
@en
Adriana L Burgueño
@es
Adriana L Burgueño
@nl
type
label
Adriana L Burgueño
@ast
Adriana L Burgueño
@en
Adriana L Burgueño
@es
Adriana L Burgueño
@nl
prefLabel
Adriana L Burgueño
@ast
Adriana L Burgueño
@en
Adriana L Burgueño
@es
Adriana L Burgueño
@nl
P106
P21
P31
P496
0000-0001-7584-7044